Following the new virus, Covid-19, otherwise known as Coronavirus pandemic spread across the globe, the experimental virus treatment drug named ”Remdesivir” has failed in its first randomised clinical trial.
Results of the trial were released on Thursday, April 23, Manila Bulletin reports.
According to a draft summary that went online briefly on the website of the World Health Organization (WHO), the Chinese trial involved 237 patients, with 158 on the drug and 79 in a control group.
Remdesivir was stopped early in 18 patients because of side effects.
After three months, 13.9 percent of the patients on remdesivir had succumbed to the deadly disease compared to 12.8 percent of those in the control group.
The difference is not statistically significant.
The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.
Meanwhile, Nigeria on Friday night, April 24, has recorded another 114 new cases of Covid-19, otherwise known as Coronavirus in eight states and Abuja, the country capital, bringing the total number of confirmed infections in the country to 1095 and 32 deaths.
Nigeria Centre for Disease Control (NCDC), made the announcement on Friday night, on its official Twitter account.
The new cases are spread across Lagos, Ogun, Gombe, Oyo, Zamfara, Edo, Kaduna and Sokoto states as well as Abuja, the country capital.
The centre also said that one person died from Coronavirus-related complications in the country, making the number of fatalities rise to 32.
NCDC said,” On the 24th of April 2020, 114 new confirmed cases of COVID-19 were recorded in Nigeria.
Till date, 1095 cases have been confirmed, 208 cases have been discharged and 32 deaths have been recorded in Nigeria.
“The 114 new cases are reported from eight states – Lagos (80), Federal Capital Territory/Abuja (5), Ogun (1), Gombe (21), Oyo (1), Kaduna (1), Edo (2), Sokoto (one) and Zamfara (2)”.
